Group One Trading’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Hold |
0
| – | – | – | 3466 |
|
2023
Q4 | – | Sell |
-23,495
| Closed | -$350K | – | 3563 |
|
2023
Q3 | $350K | Buy |
+23,495
| New | +$350K | ﹤0.01% | 606 |
|
2023
Q2 | – | Hold |
0
| – | – | – | 3554 |
|
2023
Q1 | – | Hold |
0
| – | – | – | 3443 |
|
2022
Q4 | – | Sell |
-18,932
| Closed | -$66K | – | 3481 |
|
2022
Q3 | $66K | Buy |
18,932
+8,218
| +77% | +$28.6K | ﹤0.01% | 1140 |
|
2022
Q2 | $32K | Sell |
10,714
-1,677
| -14% | -$5.01K | ﹤0.01% | 1395 |
|
2022
Q1 | $39K | Buy |
+12,391
| New | +$39K | ﹤0.01% | 1504 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 3497 |
|
2021
Q3 | – | Sell |
-11,540
| Closed | -$50K | – | 3412 |
|
2021
Q2 | $50K | Buy |
11,540
+9,897
| +602% | +$42.9K | ﹤0.01% | 1522 |
|
2021
Q1 | $7K | Sell |
1,643
-16,807
| -91% | -$71.6K | ﹤0.01% | 1679 |
|
2020
Q4 | $106K | Sell |
18,450
-8,270
| -31% | -$47.5K | ﹤0.01% | 1002 |
|
2020
Q3 | $193K | Buy |
+26,720
| New | +$193K | ﹤0.01% | 775 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 2448 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 2314 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 2301 |
|
2019
Q3 | – | Hold |
0
| – | – | – | 2291 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 2210 |
|
2019
Q1 | – | Sell |
-1,156
| Closed | -$9K | – | 2165 |
|
2018
Q4 | $9K | Buy |
+1,156
| New | +$9K | ﹤0.01% | 1154 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 2203 |
|
2018
Q2 | – | Sell |
-3,475
| Closed | -$45K | – | 2129 |
|
2018
Q1 | $45K | Buy |
+3,475
| New | +$45K | ﹤0.01% | 909 |
|
2017
Q4 | – | Hold |
0
| – | – | – | 2039 |
|
2017
Q3 | – | Sell |
-4,108
| Closed | -$24K | – | 1994 |
|
2017
Q2 | $24K | Buy |
+4,108
| New | +$24K | ﹤0.01% | 1005 |
|